3/31/2024 | 30041050 | HARMLESS MEDICINE/PHARMACEUTICAL GOODS CLOXIN DRY SYRUP 125MG/5ML (CLOXACILLIN ORAL SOLUTION 125MG/5ML) | XXXXXXXXXX | 59300 | NOS | 29958.89 | ETHIOPIA | JNPT NHAVA SHEVA SEA |
3/30/2024 | 30041050 | CLOXACILLIN CAPS.IP 250MG E.HARD GELATINCAP.CONT.CLOXACILLIN SODIUM IP EQ.TO CLOXACILLIN 250MG(10X10TAB,5140P)(CLBF-002 | XXXXXXXXXX | 514000 | NOS | 8124.17 | AFGHANISTAN | TUGLAKABAD ICD |
3/30/2024 | 30041050 | HARMLESS MEDICINE/PHARMACEUTICAL GOODS CLOXIN DRY SYRUP 125MG/5ML (CLOXACILLIN ORAL SOLUTION 125MG/5ML) | XXXXXXXXXX | 9800 | NOS | 4853.97 | ETHIOPIA | JNPT NHAVA SHEVA SEA |
3/30/2024 | 30041050 | CLOXACILLIN CAPS.IP 500MG E.HARD GELATINCAP.CONT.CLOXACILLIN SODIUM IP EQ.TO CLOXACILLIN 500MG(10X10TAB,154P)(CNBF-005 | XXXXXXXXXX | 15400 | NOS | 434.28 | AFGHANISTAN | TUGLAKABAD ICD |
3/29/2024 | 30041050 | HARMLESS MEDICINE / PHARMACEUTICAL GOODSCLOXIN CAPSULES 250MG (CLOXACILLIN CAPSULES 250MG) | XXXXXXXXXX | 7.68 | THD | 11259.63 | KENYA | JNPT NHAVA SHEVA SEA |
3/29/2024 | 30041050 | HARMLESS MEDICINE/PHARMACEUTICAL GOODS CLOXIN DRY SYRUP 125MG/5ML (CLOXACILLIN ORAL SOLUTION 125MG/5ML) | XXXXXXXXXX | 19600 | NOS | 10096.25 | ETHIOPIA | JNPT NHAVA SHEVA SEA |
3/27/2024 | 30041050 | CLOXACILLIN CAP.IP 250MG E.HARD GELATINCAP.CONT.CLOXACILLIN SODIUM IP EQ.TO CLOXACILLIN 250MG(10X10CAPS,4900P)(CLBF-001 | XXXXXXXXXX | 490000 | NOS | 7871.96 | AFGHANISTAN | TUGLAKABAD ICD |
3/27/2024 | 30041050 | PHILCO-CLOXA OS 250(CLOXACILLIN SODIUM FOR ORAL SOLUTION USP 250MG/5ML)100ML B.NO.2310070-15 TO 2310070-22 | XXXXXXXXXX | 55900 | NOS | 36254.22 | GERMANY | PATLI ICD |
3/27/2024 | 30041050 | PHILCO-IBUPA 220(IBUPROFEN 100MG & PARACETAMOL 120MG SUSPENSION)100ML, B.NO.2310073-1, M.DT.03/2024.EXP.DT.02/2027 | XXXXXXXXXX | 40100 | NOS | 14915.81 | GERMANY | PATLI ICD |
3/27/2024 | 30041050 | PHILCO -CLOXA 500 (CLOXACILLIN CAPSULESBP 500MG)10X10/BOX B.NO.2310069-11 TO 2310069-13, MFG DT.01/2024, EXP DT.12/2026 | XXXXXXXXXX | 11800 | NOS | 43891.9 | GERMANY | PATLI ICD |